ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $909,828 | +55.1% | 197,791 | +117.8% | 0.00% | 0.0% |
| Q2 2023 | $586,678 | -7.9% | 90,821 | +7.5% | 0.00% | 0.0% |
| Q1 2023 | $636,727 | -15.9% | 84,450 | +13.1% | 0.00% | -50.0% |
| Q4 2022 | $756,786 | +9.5% | 74,666 | +6.9% | 0.00% | 0.0% |
| Q3 2022 | $691,000 | +33.7% | 69,867 | +44.0% | 0.00% | +100.0% |
| Q2 2022 | $517,000 | +30.2% | 48,531 | +19.2% | 0.00% | 0.0% |
| Q1 2022 | $397,000 | +3.7% | 40,699 | +51.7% | 0.00% | 0.0% |
| Q4 2021 | $383,000 | +46.2% | 26,822 | +105.0% | 0.00% | 0.0% |
| Q3 2021 | $262,000 | +97.0% | 13,084 | +114.6% | 0.00% | – |
| Q2 2021 | $133,000 | -14.2% | 6,097 | +33.4% | 0.00% | – |
| Q1 2021 | $155,000 | +167.2% | 4,571 | +215.2% | 0.00% | – |
| Q4 2020 | $58,000 | – | 1,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |